Jordan

The Jordan Food and Drug Administration (JFDA) is the primary regulatory authority responsible for overseeing the registration and market authorization of health products in Jordan, including pharmaceuticals, medical devices, diagnostics, and increasingly digital health solutions. The JFDA operates under the Food and Drug Law No. 31 of 2008 and its subsequent amendments, which provide the legal framework for product registration, quality control, post-market surveillance, and enforcement. All health products intended for the Jordanian market must undergo a formal registration process with the JFDA before commercialization, and the authority maintains dedicated directorates for pharmaceuticals, medical devices, and food safety, each with distinct technical review pathways.

Applicants are required to submit a structured technical dossier aligned with the Common Technical Document (CTD) format for pharmaceuticals, while medical devices follow a risk-based classification system broadly consistent with international frameworks such as those of the Global Harmonization Task Force (GHTF) and the International Medical Device Regulators Forum (IMDRF). A locally registered representative or agent is mandatory for foreign manufacturers seeking product registration in Jordan. The JFDA has progressively adopted reference-country reliance procedures, accepting approvals from stringent regulatory authorities such as the US FDA, EMA, Health Canada, and others to expedite review timelines for already-approved products. Recent reforms have focused on digitizing submission workflows through the JFDA's online portal, strengthening post-market surveillance mechanisms, and aligning Jordanian standards more closely with international best practices to support the country's role as a regional pharmaceutical hub.

Public procurement of health products in Jordan is primarily managed through the Ministry of Health (MOH), which conducts centralized national tenders for pharmaceuticals, medical devices, and diagnostic supplies used across public hospitals and primary healthcare centers. The Jordan Pharmaceutical Procurement Directorate within the MOH coordinates these tenders, typically on an annual basis, and all products must be JFDA-registered to be eligible for public sector procurement. The Royal Medical Services (RMS), which serves the military and security forces, and the university hospitals also conduct independent procurement processes, resulting in a multi-channel public procurement environment. Price negotiations and cost-containment measures, including reference pricing based on countries of origin and comparator markets, are standard features of the public tendering process.

The private sector represents a significant and growing share of the Jordanian health market, operating through private hospitals, retail pharmacies, and specialty clinics that procure health products independently via local distributors and agents. Jordan also benefits from procurement channels linked to international donor and humanitarian organizations, given the country's role as a host for large refugee populations, particularly Syrians. Organizations such as UNICEF, the United Nations High Commissioner for Refugees (UNHCR), the World Health Organization (WHO), and USAID-funded programs including USAID's global health supply chain initiatives are active in Jordan and procure health commodities outside of standard MOH channels, often following their own procurement standards and pre-qualification requirements. Jordan has a relatively developed domestic pharmaceutical manufacturing sector and applies certain preferences for locally manufactured products in public tenders, consistent with national industrial development policies aimed at promoting self-sufficiency and export capacity in the health sector.